TMCI vs. SILK, ATRI, SIBN, EMBC, KIDS, IRMD, FNA, OFIX, AORT, and NVRO
Should you be buying Treace Medical Concepts stock or one of its competitors? The main competitors of Treace Medical Concepts include Silk Road Medical (SILK), Atrion (ATRI), SI-BONE (SIBN), Embecta (EMBC), OrthoPediatrics (KIDS), Iradimed (IRMD), Paragon 28 (FNA), Orthofix Medical (OFIX), Artivion (AORT), and Nevro (NVRO). These companies are all part of the "surgical & medical instruments" industry.
Treace Medical Concepts (NASDAQ:TMCI) and Silk Road Medical (NASDAQ:SILK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.
Silk Road Medical received 67 more outperform votes than Treace Medical Concepts when rated by MarketBeat users. However, 62.16% of users gave Treace Medical Concepts an outperform vote while only 51.14% of users gave Silk Road Medical an outperform vote.
84.1% of Treace Medical Concepts shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 6.7% of Silk Road Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Silk Road Medical had 3 more articles in the media than Treace Medical Concepts. MarketBeat recorded 4 mentions for Silk Road Medical and 1 mentions for Treace Medical Concepts. Silk Road Medical's average media sentiment score of 0.27 beat Treace Medical Concepts' score of 0.00 indicating that Silk Road Medical is being referred to more favorably in the news media.
Treace Medical Concepts has higher revenue and earnings than Silk Road Medical. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Silk Road Medical, indicating that it is currently the more affordable of the two stocks.
Treace Medical Concepts currently has a consensus target price of $19.58, indicating a potential upside of 90.13%. Silk Road Medical has a consensus target price of $22.18, indicating a potential upside of 25.68%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, research analysts plainly believe Treace Medical Concepts is more favorable than Silk Road Medical.
Treace Medical Concepts has a net margin of -26.47% compared to Silk Road Medical's net margin of -31.70%. Treace Medical Concepts' return on equity of -33.96% beat Silk Road Medical's return on equity.
Treace Medical Concepts has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, Silk Road Medical has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500.
Summary
Treace Medical Concepts beats Silk Road Medical on 12 of the 18 factors compared between the two stocks.
Get Treace Medical Concepts News Delivered to You Automatically
Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Treace Medical Concepts Competitors List
Related Companies and Tools
